Ivermectin 3 mg

DRUG4 trials

Sponsors

Kitasato University, Jennifer Keiser

Conditions

AscariasisCovid19HelminthiasisIntestinal WormsStrongyloides Stercoralis Infection

Phase 2

Study in COvid-19 Patients With iveRmectin (CORVETTE-01)

Kitasato UniversityCovid19

Start: 2020-09-16End: 2022-05-31Updated: 2022-01-20

Phase 3

Efficacy and Safety of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis

CompletedNCT04848688

Jennifer KeiserStrongyloides Stercoralis Infection

Start: 2022-02-05End: 2022-07-17Updated: 2024-01-25

Follow-up Assessment of Change in Soil-transmitted Helminths Infection Intensity in Uganda

Not yet recruitingNCT07873398

Jennifer KeiserAscariasis

Start: 2026-10-01End: 2027-03-01Target: 450Updated: 2026-10-14

Unknown Phase

Co-administration of IVM and ALB in School-based Deworming in Uganda

CompletedNCT06497075

Jennifer KeiserHelminthiasis, Intestinal Worms

Start: 2024-07-01End: 2024-10-19Updated: 2024-12-20

Related Papers

Efficacy and safety of moxidectin compared with ivermectin against Strongyloides stercoralis infection in adults in Laos and Cambodia: a randomised, double-blind, non-inferiority, phase 2b/3 trial.

2023-11-0710 citations

Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial

Frontiers in Medicine2023-05-225 citations

Efficacy and safety of moxidectin and albendazole compared with ivermectin and albendazole coadministration in adolescents infected with Trichuris trichiura in Tanzania: an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.

2022-10-2816 citations